from the Huffington Post about the benefits of the vaccine article Posted November 10, 2018 05:31:49A new study out of the University of Washington School of Medicine has found that a combination of the flu vaccine and the pneumococcal conjugate vaccine (PCV-9) significantly reduces the risk of developing pneumonia and hospitalization for people who take the vaccine for the first time.
In a report released today, the study, published in the journal Pediatrics, found that the combined vaccine resulted in a reduction in hospitalizations for the second year in a row.
Researchers followed more than 15,000 people who received the flu vaccination and who were not vaccinated with PCV-19, which is produced in the laboratory and is used in conjunction with the flu shot.
The researchers found that while the flu vaccines used in the study had slightly lower safety data, the combined PCV vaccine significantly reduced the risk for hospitalizations and pneumonia.
The study found that after the flu vaccinations, the researchers also measured how much longer the people stayed in hospital, and the vaccine had a significantly lower hospitalization rate than the combined flu vaccine.
The findings of the study were also consistent with a study published earlier this year by the CDC that found that combining the flu and pneumococcus vaccines reduced the number of hospitalizations after the second season of flu vaccination, but only when the people were not given the flu shots.
The new study, which was conducted by a team of researchers from the University and the Seattle Children’s Research Institute, looked at the effectiveness of PCV vaccines in the United States.
The CDC says it expects to release more data on the effectiveness and safety of PCVs in the coming months.
The study also found that people who have had the flu for more than four weeks had lower risk of hospitalization than those who were vaccinated with flu vaccine during the first year.